SYNOPSIS Motor nerve conduction velocity was measured after dosing guinea-pigs with 200-400 ,umol/kg diphenylhydantoin (DPH) daily for three to four days. Conduction velocity fell by a mean value of 13% in animals that achieved plasma DPH levels over 200 ftmol/l. There was no change in velocity with DPH levels below this value.
in velocity with DPH levels below this value.
Diphenyihydantoin (DPH) may produce mild peripheral neuropathy in patients who have received the drug for several years (Lovelace and Horwitz, 1968; Eisen et al., 1974; Chokroverty and Sayeed, 1975) . Lower limb areflexia, loss of vibration sensation, and occasional slight disturbances of other sensory modalities occur. The motor system is rarely involved and never severely. The incidence of abnormal signs appears to be related to the duration of therapy, rather than to the dose taken. Thus, in 50 unselected patients, Lovelace and Horwitz (1968) found that lower limb reflexes were absent in 18 % of patients treated for more than five years, but in 50 % of those treated for more than 15 years. Chokroverty and Sayeed (1975) examined 35 patients on DPH therapy. Three had absent reflexes and all three had been treated for more than 10 years. Some reduction in nerve conduction velocity has also been demonstrated in patients receiving the drug for many years, even without abnormal signs (Lovelace and Horwitz, 1968; DeCastro et al., 1972; Eisen et al., 1974; Encinoza, 1974; Chokroverty and Sayeed, 1975) .
In distinction from a mild chronic effect on peripheral nerve function after exposure to DPH for many years, the drug appears to have an acute effect on conduction velocity when given in high doses. When intravenous DPH was given to rabbits Morrell et al. (1958) found some increase in conduction time (Accepted 14 May 1976.) in the posterior tibial nerve, as well as effects on other parameters of nerve excitability. In man, Hopf (1968) found that after treatment for 11 days there was an increase in the range of conduction velocity in the ulnar nerve. There was no effect on maximal velocity, thus suggesting that the smaller and slower conducting fibres were more affected. Birkett-Smith and Krogh (1971) (Fullerton, 1966) .
Maximum motor nerve conduction velocity was measured in the fibres supplying the small muscles on the plantar surface of the hind limb, using the technique described by Fullerton (1966) . Animals were anaesthetised with intraperitoneal pentobarbitone, supplemented, when necessary, by fluothane given with oxygen through a facial mask. Supramaximal shocks were applied to the sciatic nerve in the upper thigh and to the posterior tibial nerve at the ankle. Muscle action potentials were recorded through subcutaneous needle electrodes, one over the middle of the bellies of the interosseous muscles and the other beside the tendon of the lateral toe. Limb temperature was maintained by laying the animals on a heated operating table and by radiant heat from a lamp. Care in maintaining limb temperature was particularly important in ill animals. Subcutaneous thigh temperature was always 36°C-380C.
In 18 control animals conduction velocity was measured on two occasions at intervals of three days to four weeks. This gave an indication of the range of variation to be expected in repeated estimations using this technique. In 38 animals conduction velocity was measured before and after dosing with DPH.
Diphenylhydantoin sodium was administered orally by stomach tube. Material from capsules of diphenylhydantoin (Parke Davies) was suspended in methyl cellulose 2500 gel 20% (diluted to a final concentration of 0.5 %) to give a DPH concentration in the suspension of 100 mmol/l. DPH was given in doses ranging from 200-400 Hmol/kg/day (Table 1) .
These doses are considerably higher than those given therapeutically to man, but were used in an attempt to achieve plasma concentrations in the range known to be toxic to man.
In the majority of animals conduction velocity was measured three hours after the last dose, and 2 ml blood were then taken by cardiac puncture. In some severely ill animals conduction velocity was measured 24 hours after dosing, as they were considered to be too ill to receive a further dose on the day conduction velocity was estimated. In four animals who survived and who achieved high plasma DPH levels (over 200 Hmol/l), conduction velocity was measured again between one and three weeks later, during which time no further DPH was given.
DPH levels were estimated on heparinised samples of blood either by a modification of the gas liquid chromatographic method of MacGee (1970) as described by Vajda et al. (1974) , or by a combination of the extraction method of Toseland et al. (1972) and the GLC method of MacGee (1970), as described by Goldberg et al. (1974) . These methods are widely accepted as specific, accurate, and reproducible (Meijer et al., 1973; Eadie and Tyrer, 1974 Figure 1 shows the results of maximal motor nerve conduction velocity determination. The control group consists of animals in whom conduction velocity was estimated on two occasions at intervals of three days to four weeks. The mean value for the first reading was 52 m/s and for the second reading was 51 m/s. The animals treated with DPH were divided into three groups on the basis of the plasma DPH levels achieved; less than 120 Htmol/l, 120-200 /imol/l, and above 200 ,umol/l. In all animals conduction velocity was measured before and after dosing.
The paired t test was used to compare the first and second estimations of conduction velocity (Table 2) Percentage change in conduction velocity between the first and second estimations is shown in relation to the plasma DPH concentration achieved in Fig. 2 . It can be seen that in animals that had achieved levels of less than 200 ,lmol/l there was little effect on conduction. In animals with levels above this value, conduction velocity fell in all.
Percentage change in conduction velocity is shown for the different groups of animals in Fig. 3 Kutt et al. (1964) found that nystagmus occurred when plasma levels were 15-30 ,ug/ml (60-120 jtmol/l), ataxia was evident at 30-40 jug/ml (120-160 Pmol/l), and above this level blurred vision, mental changes, and gross incoordination developed. There are no available data about DPH metabolism in the guinea-pig. In rats, rabbits, and man there is evidence that the drug is cumulative and that the plasma level is maintained for longer at a constant level after repeated doses than after a single dose (Dill et al., 1956; Arnold and Gerber, 1970) . It was therefore decided to measure conduction velocity in guinea-pigs after DPH had been administered for three or four days, although we cannot be sure that the plasma level was stable. However, blood samples were taken immediately after velocity was measured. It is known in general that the concentration of a drug at its site of action is in physicochemical equilibrium with the drug concentration in plasma. In other words, the plasma level is related to the pharmacological effect (Brodie, 1964) . Thus, it is reasonable to correlate nerve conduction velocity with plasma drug level, and indeed a statistically significant correlation was found.
The mechanism responsible for the reduction in conduction velocity has not been elucidated. Velocity was reduced only in animals with high DPH levels which were clinically in a poor general condition. It might be suggested that the reduction in velocity was due to a general metabolic disturbance, possibly partly related to low food and water intake. However, velocity has been found to be unaffected in equally sick animals intoxicated with other substances (personal observations). Alternatively, the effect might be due to early changes in the development of a demyelinating or axonal neuropathy. Again, this seems unlikely because the change in conduction velocity occurs within a few days of exposure and limited observations suggest that the effect might be reversible within a short time.
It seems probable that the reduction in conduction velocity demonstrated in these experiments has a different cause from the chronic effect of long-term DPH administration. The acute effect appears to be reversible within a short time and is possibly due to a specific metabolic disturbance, whereas it seems likely that changes are longer lasting or permanent when they occur after treatment for many years. Further experiments are planned to investigate the time relation of change in velocity and exposure to DPH in more detail.
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